HIEs reduce redundant therapeutic services

Participating in an health information exchange (HIE) “significantly” reduced repetition of therapeutic procedures by providers in western New York, according to research conducted by the State University of New York (SUNY) and the Brookings Institution.

The study, led by SUNY PhD candidate Saeede Eftekhari, compared Medicare claims data to the regional HIE for western New York, HEALTHeLINK, for 122 diagnostic (defined as tests to diagnose or measure the severity of a medical issue) and 149 therapeutic (defined as treatments to help, cure, improve or restore function to a patient) medical procedures that were performed at both participating and non-HIE providers.

As the researchers expected, HIE adoption didn’t have any impact on diagnostic procedures. For therapeutic procedures, however, the study found using a HIE led physicians to avoiding redoing those procedures, which could have a “significant impact on reducing unnecessary repetitions.”

According to an accompanying blog post by Brookings, the study said a physician that performs a specific therapeutic medical procedure 100 times for 73 unique patients repeats the procedure 27 times, an average ratio of repetition of 0.27 After one year of experience with the HIE, the average ratio of repetition for the physician will fall to 0.26—meaning the physician would perform that test 98 times for the same 73 patients, avoiding 2 repetitions.

If those results were expanded to the entire United States, the study said $63 million in Medicare spending could be saved every year for reducing unnecessary therapeutic procedures.

“To the best of our knowledge, prior studies on the outcomes of HIE participation were limited to the emergency departments and therefore our understanding of the outcomes of HIE participation in other settings including physicians’ offices and medical practices was very limited,” Eftekhari and her coauthors wrote. “Our paper bridges this gap in the literature and contributes to the theory by building and testing a set of hypotheses on the benefits of HIE participation on repetition of therapeutic and diagnostic medical procedures at the physicians’ offices.”

With evidence that HIEs can be effective in decreasing costs and improving quality, Eftekhari and her coauthors concluded it would lead to “improved information and data management at HIEs, extended scope and reach of their services to its members, all leading to sustainable HIE business models which seem to be in their infancy at this time.”

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.